Early screening urged to reduce pre-eclampsia risk
Researchers from Chinese University on Thursday called for the implementation of a proactive screening and prevention strategy to tackle the serious pregnancy complication pre-eclampsia. Pre-eclampsia, a condition that typically manifests after 20 weeks of pregnancy, is characterised by high blood pressure, elevated urine protein levels indicating kidney damage, and other signs of organ dysfunction. The researchers said pregnant women should be screened for pre-eclampsia, with those at risk given low-doses of aspirin as a preventative measure. They said their recommendation follows a study conducted with partners across Asia which showed the effectiveness of such a preventative approach, with the practice already established in Europe. The study showed that the strategy can significantly cut the incidence of pre-eclampsia by between 41 and 54 percent, as well as reducing premature births and perinatal deaths by more than 50 percent. Liona Poon, professor of obstetrics at the university, highlighted the critical nature of the condition, saying it poses a serious threat to both mother and baby. "In the worst case scenario, the woman can present with seizures and this is what we are very worried about... It's a life-threatening condition for herself as well as her unborn child," she said.  "So why do we recommend early screening? It's because there is strong evidence suggesting that there is a way of preventing pre-eclampsia and that is giving high-risk women aspirin. Aspirin should be started before 16 weeks of gestation." The university's study involved nearly 43,000 pregnant women in Hong Kong and nine other places in Asia.